A Comparison of Morbidity Between Patients With Pulmonary Atresia With Intact Ventricular Septum and Uni- or Biventricular Circulation
A Longterm Follow-up and Comparison of Morbidity and Heart Health Between Patients With Pulmonary Atresia With Intact Ventricular Septum and Uni- or Biventricular Circulation
1 other identifier
observational
140
1 country
1
Brief Summary
The goal of this observational study is to compare patients with pulmonary atresia with intact ventricular septum (PA-IVS) with univentricular circulation to patients with the same heart defect but that has a biventricular circulation in regards to mortality, quality of life, comorbidity, cardiac function, and work capacity. The main questions the study aims to answer are: • Do mortality, quality of life, comorbidity, cardiac function, and work capacity differ between patients with PA-IVS who have univentricular and biventricular circulation? Participants will be asked to answer a Quality of Life questionnaire. The investigators will also inquire with a sample size of the research subjects (based on place of residence) about their participation in a series of examinations (ergo-spirometry to assess work capacity, transthoracic echocardiogram, magnetic resonance of the heart and blood sampling to assess cardiac function and cardiac health).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Jul 2024
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
June 4, 2023
CompletedFirst Posted
Study publicly available on registry
July 3, 2023
CompletedStudy Start
First participant enrolled
July 15, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2026
CompletedMarch 30, 2025
March 1, 2025
1.4 years
June 4, 2023
March 25, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
Difference in comorbidity between the two groups
Difference in myocardial infarction, heart failure, arrhythmia, stroke, malignancy, autoimmune diseases, infections, atopy, certain liver diseases, and protein-losing enteropathy between the two groups
September 2024
Secondary Outcomes (5)
Difference in quality of life between the two groups
September 2024
Difference in physical capacity between the two groups
September 2024
Difference in cardiac capacity between the two groups
September 2024
Difference in general health, linked to cardiac health, between the two groups
September 2024
Difference in mortality between the groups
September 2024
Study Arms (2)
Biventricular circulation
Research subjects with PA-IVS who have biventricular circulation
Univentricular circulation
Research subjects with PA-IVS who have univentricular circulation
Eligibility Criteria
The study population consists of all individuals with PA-IVS who have been registered in Swedcon (a national register for patients with congenital heart defects) or in the National Patient Register and Cause of Death Register since 1980 and meet other inclusion criteria, including age.
You may qualify if:
- Individuals born with pulmonary atresia with intact ventricular septum (PA-IVS) who are 15 years or older at the start of the study.
- Regarding the mortality variable, research subjects who have died after the age of 15 years old will be included.
You may not qualify if:
- Individuals born with pulmonary atresia with intact ventricular septum who are younger than 15 years old at the start of the study.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Pediatric Heart Center, Queen Silvia's Children's hospital
Gothenburg, 416 85, Sweden
MeSH Terms
Conditions
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER GOV
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- MD
Study Record Dates
First Submitted
June 4, 2023
First Posted
July 3, 2023
Study Start
July 15, 2024
Primary Completion
December 1, 2025
Study Completion
January 1, 2026
Last Updated
March 30, 2025
Record last verified: 2025-03